Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation

Abstract While efficacious vaccines have been developed to inoculate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; also known as COVID-19), public vaccine hesitancy could still undermine efforts to combat the pandemic. Employing a survey of 1096 adult Americans recruited via t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sarah Kreps, Nabarun Dasgupta, John S. Brownstein, Yulin Hswen, Douglas L. Kriner
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/947f2f7efcdc4aa590bdee97f614c137
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:947f2f7efcdc4aa590bdee97f614c137
record_format	dspace
spelling	oai:doaj.org-article:947f2f7efcdc4aa590bdee97f614c1372021-12-02T15:54:45ZPublic attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation10.1038/s41541-021-00335-22059-0105https://doaj.org/article/947f2f7efcdc4aa590bdee97f614c1372021-05-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00335-2https://doaj.org/toc/2059-0105Abstract While efficacious vaccines have been developed to inoculate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; also known as COVID-19), public vaccine hesitancy could still undermine efforts to combat the pandemic. Employing a survey of 1096 adult Americans recruited via the Lucid platform, we examined the relationships between vaccine attributes, proposed policy interventions such as financial incentives, and misinformation on public vaccination preferences. Higher degrees of vaccine efficacy significantly increased individuals’ willingness to receive a COVID-19 vaccine, while a high incidence of minor side effects, a co-pay, and Emergency Use Authorization to fast-track the vaccine decreased willingness. The vaccine manufacturer had no influence on public willingness to vaccinate. We also found no evidence that belief in misinformation about COVID-19 treatments was positively associated with vaccine hesitancy. The findings have implications for public health strategies intending to increase levels of community vaccination.Sarah KrepsNabarun DasguptaJohn S. BrownsteinYulin HswenDouglas L. KrinerNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-7 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Sarah Kreps Nabarun Dasgupta John S. Brownstein Yulin Hswen Douglas L. Kriner Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation
description	Abstract While efficacious vaccines have been developed to inoculate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; also known as COVID-19), public vaccine hesitancy could still undermine efforts to combat the pandemic. Employing a survey of 1096 adult Americans recruited via the Lucid platform, we examined the relationships between vaccine attributes, proposed policy interventions such as financial incentives, and misinformation on public vaccination preferences. Higher degrees of vaccine efficacy significantly increased individuals’ willingness to receive a COVID-19 vaccine, while a high incidence of minor side effects, a co-pay, and Emergency Use Authorization to fast-track the vaccine decreased willingness. The vaccine manufacturer had no influence on public willingness to vaccinate. We also found no evidence that belief in misinformation about COVID-19 treatments was positively associated with vaccine hesitancy. The findings have implications for public health strategies intending to increase levels of community vaccination.
format	article
author	Sarah Kreps Nabarun Dasgupta John S. Brownstein Yulin Hswen Douglas L. Kriner
author_facet	Sarah Kreps Nabarun Dasgupta John S. Brownstein Yulin Hswen Douglas L. Kriner
author_sort	Sarah Kreps
title	Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation
title_short	Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation
title_full	Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation
title_fullStr	Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation
title_full_unstemmed	Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation
title_sort	public attitudes toward covid-19 vaccination: the role of vaccine attributes, incentives, and misinformation
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/947f2f7efcdc4aa590bdee97f614c137
work_keys_str_mv	AT sarahkreps publicattitudestowardcovid19vaccinationtheroleofvaccineattributesincentivesandmisinformation AT nabarundasgupta publicattitudestowardcovid19vaccinationtheroleofvaccineattributesincentivesandmisinformation AT johnsbrownstein publicattitudestowardcovid19vaccinationtheroleofvaccineattributesincentivesandmisinformation AT yulinhswen publicattitudestowardcovid19vaccinationtheroleofvaccineattributesincentivesandmisinformation AT douglaslkriner publicattitudestowardcovid19vaccinationtheroleofvaccineattributesincentivesandmisinformation
_version_	1718385463233871872

Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation

Ejemplares similares